
Under the leadership of Professor Patricia Connolly (right) and her researchers, the technology consists of a fully programmable, reverse iontophoresis device to which screen printed, gel-coated electrodes are attached.
Preliminary studies in human volunteers looking at detection/ measurement of glucose and lactate suggested that the device could accurately and reproducibly detect glucose through the skin.
The skin electrode/biosensor system will soon be capable of detecting and measuring glucose and lactate in real time.
The device promises increased convenience due to its non-invasive nature. It is also portable and can extract a number of blood-circulating molecules for a wide variety of analytical uses. It could be used at home, or in clinic and hospitals.
Since the device is programmable and multi-parameter, it has the capability to extract a number of other blood analytes, for example, lactate in sports applications.
Strathclyde University is looking for partners interested in developing, licensing or exploiting this technology.